Laboratory-Treated T Cells After Second-Line Chemotherapy in Treating Patients With HER2/Neu-Negative Metastatic Breast Cancer
Clinical trial NCT01022138 · TERMINATED
Trial details
- NCT number
- NCT01022138
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-08
- Primary completion
- 2015-11-06
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.